Notice of Financial Statement and Annual Report
Faron Pharmaceuticals will publish 2024 financial statements and annual report on 27 February 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
Faron Pharmaceuticals will publish its Financial Statement Release 2024 and Annual Report 2024 on Thursday, 27 February 2025
Press Release, 19 February 2025
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, will publish its Financial Statement Release 2024 and Annual Report 2024 on Thursday, 27 February 2025. The Financial Statement Release and Annual Report will be available on Faron Pharmaceuticals' investor website https://faron.com/investors/.
A webcast is scheduled on the same day at 9am GMT / 11am EET for analysts, investors and media. During the webcast, CEO Juho Jalkanen and CFO Yrjö Wichmann will deliver a presentation on the results. The webcast will be conducted in English.
The webcast can be followed at: https://faron.events.inderes.com/q4-2024
The presentation material and the webcast recording will be available on Faron Pharmaceuticals' investor website.
About bexmarilimab
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.